ℹ️
🇬🇧
Search
Search for people relevant for "poor prognosis"
poor prognosis
Person
Class
Person
Publication
Programmes
MUDr. Věra Vozobulová
Person without affiliation with CUNI
16 publications
Publications
publication
Angioimmunoblastic T-cell Lymphoma as a Very Poor-Prognosis Malignancy – a Single Centre Experience
2012 |
Central Library of Charles University, Faculty of Medicine in Pilsen
publication
Léčebné postupy v hematologii 2020. Doporučení České hematologické společnosti České lékařské společnosti Jana Evangelisty Purkyně
2020 |
First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, Second Faculty of Medicine
publication
Generalized Clostridial sepsis (Cl. Perfringens) with multiple organ abscesses in a patient with refractory very severe aplastic anemia (VSAA): haploid hematopoietic stem cell transplantation as the ultimum refugium
2018 |
Publication without faculty affiliation
publication
Doporučení ČHS pro diagnostiku a léčbu imunitní trombocytopenie (ITP)
2017 |
First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
publication
Radiotherapy Indications in Patients with Hematological Malignancies During the Five Years Course of Modernized Center of Oncology and Radiotherapy Clinic in Pilsen
2016 |
Faculty of Medicine in Pilsen
publication
The role of rituximab maintenance in elderly patients with mantle cell lymphoma in first remission - single centre experience
2015 |
Faculty of Medicine in Pilsen
publication
Discontinuation of biological therapy with tyrosine kinase inhibitors in chronic myeloid leukemia patients
2014 |
Faculty of Medicine in Pilsen
publication
Are we justified to classify patients with two unrelated clones with del(5q) and trisomy 8 as a subgroup of myelodysplastic syndrome of the type of 5q-syndrome?
2014 |
First Faculty of Medicine
publication
Spontaneous Remission of Acute Myeloid Leukemia – a Single Center Case Reports
2013 |
Central Library of Charles University
publication
Initial experience of Czech MDS Group with 5-azacytidine in patients with high risk myelodysplastic syndromes (IPSS intermediate II and high), acute myeloid leukaemia with less than 30% myeloblasts and chronic myelomonocytic leukaemia II
2013 |
First Faculty of Medicine
Load more publications (6)
Loading network view...